Adults with ADHD show consistent deficits in iron (ferritin <30 ng/mL in 84%), vitamin D (6.5 ng/mL lower), zinc, and magnesium. Supplementing these deficiencies produces measurable symptom improvements — particularly ferritin optimization (target >50 ng/mL), vitamin D (4000 IU/day), and zinc (15–30mg). L-tyrosine shows no benefit and develops tolerance. Screen for deficiencies before supplementing; prioritize iron and vitamin D testing.
28 sources 3/4 moderate Updated 2026-04-15
A seven-compound nutraceutical protocol (Omega-3 EPA ≥60%, Saffron 30mg, SAM-e, L-Methylfolate, Zinc, Curcumin+piperine, Magnesium glycinate) has demonstrated adjunctive efficacy for anxiety and depression across multiple RCTs and meta-analyses. Omega-3 EPA (≥1g/day) reduces depressive symptoms with effect size d≈0.61 in meta-analysis; Saffron 30mg/day matches fluoxetine 20mg in multiple head-to-head RCTs (n=40–60 per study). SAM-e (800–1600mg) and L-Methylfolate (15mg) show strong evidence specifically as SSRI augmentation. This protocol is intended as an adjunct to, not replacement for, standard psychiatric care.
22 sources 4/4 strong Updated 2026-04-15
Creatine monohydrate at 3–5g/day saturates muscle stores in 3–4 weeks; loading (20g/day for 5–7 days) accelerates this. For larger individuals (90kg+), 5–10g/day maintenance may be optimal. Cognitive benefits are strongest in sleep-deprived individuals, vegetarians, and older adults. Safety data supports doses up to 30g/day long-term with no adverse effects on kidney or liver function.
24 sources 4/4 strong Updated 2026-04-15
Systematic supplementation targeting nutrient deficiencies can significantly reduce PPD risk. Key interventions: omega-3 (EPA-dominant, 2-3g/day), ferritin optimization (>50 μg/L), vitamin D (4000-6000 IU), magnesium glycinate (300-600mg), and L. rhamnosus HN001 probiotic. A three-phase protocol (prenatal → critical postpartum → extended) addresses the neurobiological cascade triggered by postpartum hormone collapse.
47 sources 4/4 strong Updated 2026-04-13